Christin Melton

"Precision, personalized, individualized, targeted" - most oncologists are well acquainted with these terms. On Tuesday, President Obama introduced this concept to the nation in his State of the Union Address.

The New York State Stem Cell Science Program recently awarded a 4-year $11.9 million grant to Roswell Park Cancer Institute to fund research and development of a stem-cell based treatment for ovarian cancer.

The Emperor of All Maladies bills itself as a "biography of cancer," and while author Siddhartha Mukherjee cannot tell us precisely when cancer opened its eyes in this world...

Medulloblastoma, a malignant brain tumor that most commonly affects children, is not one disease but several, said researchers with St. Jude Children's Hospital in Memphis, Tennessee.

Researchers have ruled out race as a prognostic factor for overall survival (OS) in black patients with a lung cancer diagnosis.

We have dedicated several pages of our final issue of 2010 to exploring the nearly 40 years that have elapsed since the National Cancer Act was signed in 1971.

Much has transpired in the 40 years since President Richard Nixon announced that finding a cure for cancer would be one of his administration's top priorities.

In our last issue, we published a review of treatment options for acute and delayed chemotherapy-induced nausea and vomiting. Since then, a few things have happened on this front.

Author of six bestselling books, a television and film actor, and a filmmaker; Abdul-Jabbar is gaining fame for a role he never wanted: that of a chronic myeloid leukemia (CML) patient.

Siddhartha Mukherjee, MD, discusses his book The Emperor of All Maladies.

Androgen-deprivation therapy (ADT) is a widely accepted treatment for men with advanced or metastatic prostate cancer.

Data presented at the recent 35th European Society for Medical Oncology Congress in Milan, Italy, showed a significant survival advantage for men with advanced metastatic castration resistant prostate cancer (CRPC) who received abiraterone acetate compared with placebo.

In a phase III randomized trial, overall survival (OS) was more than 34% longer for patients with advanced melanoma who received the novel agent ipilimumab

Patients with cancer whose treatment includes any drug that inhibits signaling via the vascular endothelial growth factor (VEGF) pathway should receive regular blood pressure (BP) monitoring according to a panel of experts convened by the Angiogenesis Task Force of the National Cancer Institute Investigational Drug Steering Committee.

To help physicians manage the complexities of meeting benchmarks and reporting their compliance to payers, US Oncology recently announced Payer Quality Services. This program will give physicians in the United Network of US Oncology access to a collection of resources and tools, including the Level I Pathways Program.

Two studies presented at the 2010 Digestive Disease Week support the use of colonoscopy in elderly African Americans and Hispanics.

PLX4032 is an investigational treatment for metastatic melanoma, which some are calling a �miracle cure� following a 3-part article in the New York Times that discussed promising patient responses. A closer reading of the article makes it clear that PLX4032 does not cure metastatic melanoma, something Keith Flaherty, MD, a lead investigator on PLX4032, has confirmed in an interview with Oncology & Biotech News.

In a presentation at the Third Annual Interdisciplinary Prostate Cancer Congress (IPCC), Howard M. Sandler, MD, MS, a Ronald H. Bloom Family Chair in Cancer Therapeutics and professor and chair of the Department of Radiation Oncology at Cedars Sinai Medical Center in Los Angeles,

Even if you did not support the American Recovery and Reinvestment Act, commonly known as the stimulus package, you should be aware that one of its provisions—the HITECH Act—could help or hinder your future income.